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Decipheringregulatoryeventsthatdrivemalignanttransformation representsamajorchallengefor
systems biology. Here, we analyzed genome-wide transcription proﬁling of an in vitro cancerous
transformation process. We focused on a cluster of genes whose expression levels increased as a
function of p53 and p16
INK4Atumorsuppressors inactivation. This cluster predominantly consists of
cell cycle genes and constitutes a signature of a diversity of cancers. By linking expression proﬁles
of the genes in the cluster with the dynamic behavior of p53 and p16
INK4A, we identiﬁed a promoter
architecture that integrates signals from the two tumor suppressive channels and that maps their
activity onto distinct levels of expression of the cell cycle genes, which, in turn, correspond to
different cellular proliferation rates. Taking components of the mitotic spindle as an example, we
experimentally veriﬁed our predictions that p53-mediated transcriptional repression of several of
these novel targets is dependent on the activities of p21, NFY, and E2F. Our study demonstrates how
a well-controlled transformation process allows linking between gene expression, promoter
architecture, and activity of upstream signaling molecules.
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Introduction
Cellular processes are controlled by highly intricate regulatory
networks (Tavazoie et al, 1999; Pilpel et al, 2001; Werner,
2001; Ihmels et al, 2002; Lee et al, 2002; Shen-Orr et al, 2002;
Bar-Joseph et al, 2003; Segal et al, 2003; Sharan et al, 2003,
2004). Most successes to date in understanding such net-
works were obtained in lower organisms; extension to
mammalian genomes is complicated in part due to the
complexity of the promoter and enhancer regions and also
due to the tremendous intricacy of some of the regulatory
circuits. Nevertheless, initial studies, for example, in ﬂy and in
mammalian organisms, succeeded in delineating promoter
elementscontrollingparticularnetworksofgenes(Wasserman
et al, 2000; Berman et al, 2002, 2004; Halfon et al, 2002; Elkon
et al, 2003; Werner et al, 2003; Thompson et al, 2004; Smith
et al, 2005; Sumazin et al, 2005; Zhu et al, 2005). Recent
studies (Segal et al, 2003) explored an additional level in
the signaling network in yeast, namely links between
gene expression proﬁles and activity of signaling molecules.
Here too, extension to higher organisms is complicated
by the considerable increase in the intricacy of network
architecture.
In addition to deciphering normal physiological processes,
elucidation ofregulatoryandsignaling networks isexpected to
allow better understanding of pathological conditions, such
as cancer (Segal et al, 2004). Monitoring gene expression
changesonagenome-widescaleisapowerfulmethodtostudy
transcriptional programs involved in carcinogenesis (Liotta
et al, 2000; Cho et al, 2001; Whitﬁeld et al, 2002). Indeed,
speciﬁc expression signatures that correlate with speciﬁc
diagnosis, survival, and response to therapy were proposed
(Liotta et al, 2000; Scherf et al, 2000; Rosenwald et al, 2003).
Yet, associations of those signatures with speciﬁc biological
processes or with distinct genetic alterations acquired by
cancercells alongin vivotransformationsare notobvious.The
difﬁculties largely stem from different genetic backgrounds
of patients,variableanduncharacterizedmutations in tumors,
and the uncontrolled contaminations by inﬂammatory, endo-
thelial, and stroma cells.
Thus, in order to obtain novel and more reliable insights
into genetic networks associated with oncogenesis, we have
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Article number: 2005.0022recently developed an in vitro model for cellular transforma-
tion (Milyavsky et al, 2003). The 600-day-long transformation
process (Figure 1A) started with normal human ﬁbroblasts
that entered replicative senescence after 40 population
doublings. In order to overcome replicative senescence, the
cells were infected with human telomerase (hTERT), resulting
in immortalization, which was then followed by increased
proliferation rate. At that stage, cells lost expression of
the p16
INK4A (p16 for short) and p14
ARF tumor suppressors
(Milyavsky et al, 2003). To explore the transcriptional and
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Figure 1 (A) Outline of the malignant transformation process. Schematic representation of the spontaneous (young, senescent, immortal, tumorigenic, INK4A
methylation) and induced (hTERT, H-Ras, p53 inactivation) modiﬁcations of the WI-38 cells along the process of malignant transformation. The stages chosen for
microarray proﬁling are indicated byboxes withnumerals corresponding to columns inthe expression matrix shown in(B). The time scale of the process is depicted by a
horizontal axis, and the corresponding population doublings are represented by PDLs. (B) The normalized expression levels of the 168 genes in the proliferation cluster
at12stagesspanning thetransformation process.Normalizedexpressionlevel iscolor-codedaccordingtothecolorbaronthe right.Thetablebelow thematrix contains
the following information on each sample: days in culture, geometric mean and standard deviation of expression level of the cluster’s genes, doubling rate (cell cycle
doublings/day) of cells at selected stages, activity of hTERT (designated as ‘þ’ for all samples following hTERT overexpression), activity of p53, as inferred from the
application of its dominant-negative peptide, GSE56 (‘ ’ indicates expression of GSE56). Here and throughout the paper, the following cell line designations are
introduced:cellsareeitheryoungorsenescent;growsloworfast;asamplenamefollowedby‘G’denotestheapplicationofGSE56;Tbeforesamplenamesindicatesthe
presence of the immortalizing telomerase; R following the sample name indicates the insertion of Ras.
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tion process, the p53 protein was inactivated by expression of
a dominant-negative p53 peptide (GSE56) (Ossovskaya et al,
1996). These manipulations, in conjunction with H-ras over-
expression, gave rise to cells that are capable of forming
tumors in nude mice (Milyavsky et al, 2005). Recent studies
havedescribedsimilarinactivationofp16inadditionalhuman
cell lines that overcame telomere-independent crises during
immortalization (Tsutsui et al, 2002; Taylor et al, 2004).
Furthermore, using various experimental models, it was
shown that full transformation could be achieved by the
combination of viral oncogenes together with cellular genes
(Hahn et al, 1999; Voorhoeve et al, 2003). Collectively, these
experimental setups generated a model of deﬁned genetic
aberrations that initiate and promote the neoplastic process.
We have previously suggested that our in vitro cellular
systemreproducessomeofthedistinctstagesthatcharacterize
tumorinitiationandprogression(Milyavskyetal,2005).Inthe
present study, we aimed at deciphering the transcriptional
networks associated with malignant transformation. We
utilized genome-wide mRNA expression proﬁling of the
transformation process using the Human Genome Focus Array
(Affymetrix, Santa Clara, CA) with 8500 veriﬁed human genes
(Milyavsky et al, 2005). Subsequent cluster analysis of the
expression proﬁles identiﬁed 10 stable clusters. One of them,
the ‘proliferation cluster’ (Milyavsky et al, 2005), showed a
pronounced sensitivity to the status of p53 and p16 tumor
suppressors. A large number of the genes found in this
proliferation cluster also clustered in studies that analyzed
human primary tumor samples (Alizadeh et al, 2000; Perou
et al, 2000; Barrett et al, 2003; Rosty et al, 2005). In addition,
the proliferation cluster genes were found to be signiﬁcantly
more highly expressed in tumors obtained from patients with
bad outcome compared to patients with good outcome in
breast cancer (Dai et al, 2005; Milyavsky et al, 2005). These
ﬁndings strongly support the notion that the proliferation
cluster genes are highly relevant to naturally occurring
cancers.
Here, we revealed how the promoters of the cluster’s genes
generate a transcriptional program that integrates the activity
of tumor suppressors. By linking expression proﬁles of the
genes in the cluster with the dynamics of p53 and p16, we
identiﬁed two promoter architectures that integrate different
signalsfromthetwotumorsuppressivechannels andthat map
their activity onto distinct levels of expression of the cell cycle
genes, which, in turn, correspond to different cellular
proliferation rates.
Results
The ‘proliferation cluster’
Our expression cluster analysis during the transformation
process identiﬁed 10 stable clusters (Milyavsky et al, 2005).
According to the superparamagnetic clustering method (Blatt
et al, 1996), a stable cluster is one that is robust against
perturbing the data; on the one hand, the points that belong
to it are (relatively) remote from other points and, on the
other hand, they constitute a well-deﬁned entity, that is, a
(relatively)contiguous region ofhigh density. The algorithm is
capable of identifying such clusters irrespective of their shape.
It also provides a quantitative measure of the stability of
clusters.
Here we focus on one of these clusters, termed the
‘proliferationcluster’(duetoitsgenes’annotation;seebelow).
The cluster has a somewhat elongated shape, yet it is stable
and cannot be naturally divided into subclusters (Supplemen-
tary Figure S1). We decided to focus on this cluster since
the genes that constitute it showed a complex behavior—
pronounced sensitivity to the status of p53 and p16 tumor
suppressors.
Figure 1B shows expression proﬁles of the 168 genes of the
proliferation cluster along with the cells’ doubling rates and
telomerase and p53 activity. Four major states are distin-
guished. (1) The ‘young-cell period’ (ﬁrst and second columns
in the matrix) spans the ﬁrst cell cycles. During this period, the
cells are young and the expression proﬁles of the genes in
the cluster are relatively high. At the second point during the
young-cell period, a separate cell culture was derived from the
above culture, which was treated by introduction of the p53
dominant-negative peptide, GSE56. The cluster genes res-
ponded by upregulation (mean expression was signiﬁcantly
elevated from 406.5 to 479.5, P-value¼3.1 10
 23 by paired
t-test).(2)Thesenescenceperiod(thirdandfourthcolumns)is
characterized by arrest of cell divisions. The expression level
of the genes in the cluster was dramatically decreased during
this period. Yet, even within this period, expression proﬁles of
thegenesintheclusterweresigniﬁcantlyelevatedatthefourth
time point compared to the third point, that is, in response to
p53 inhibition (P-value¼7.1 10
 28 by paired t-test). (3) The
‘slow immortalization’ period (5–7th columns) is charac-
terized by expression levels similar to those in young cells.
(4) The ‘fast immortalization’ stage (8–12th columns),
associated with silencing of p16 (Milyavsky et al, 2005), is
characterized by a signiﬁcant shortening of the cell cycle
period (see table below expression matrix), accompanied by
furtherincreaseintheexpressionlevelsoftheclustergenes.At
the last two points of this period, GSE56 was reintroduced,
and the genes in the cluster responded by signiﬁcant
(P-value¼1.4 10
 32) upregulation. Thus, the expression
proﬁles of the genes in the proliferation cluster correlate with
p53 and p16 as well as with the rate of cell proliferation.
We next examined functional annotations of the genes in
the cluster, using ‘Gene Ontology’ (Ashburner et al, 2000).
Notably, only cell cycle-related functions are signiﬁcantly
over-represented (Dennis et al, 2003) in the cluster (see
Supplementary Table S1). We thus termed the cluster ‘the
proliferationcluster’.The genesintheclusterrelatetodifferent
cell cycle phases, such as DNA replication (MCM2, MCM3,
MCM5, MCM6, RRM1–2, RFC3–5, GMNN, POLA, POLD1,
POLE, POLQ, PRIM1) and DNA repair (BLM, BRCA1, MSH6).
G2/M phase genes represented the largest functional category.
Cyclin-dependent kinase CDC2, whose function is critical for
mitotic entry, and its regulators such as cyclin B2, CDC25A,
and CDC25C are included, in addition to genes involved
in mitotic spindle organization (CENPA, CENPF, TTK, BIRC5,
kinesins), spindle checkpoint (BUB1, BUB1B, MAD2L1,
CDC20), chromosome segregation (PTTG1, CENPF, ESPL1,
UBE2C, PLK1, STK12), DNA packaging (HAT1, CHC1,
SUV39H1, TOP2A), and chromosome organization (H1FX).
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cluster display high cell cycle periodicity, especially peaking at
the entry into the S and M phases (Supplementary Figure S2)
during HeLa cells divisions (Whitﬁeld et al, 2002).
In addition, we note that expression of these genes corre-
lates with poor outcome and prognosis in patients samples
(Milyavskyetal,2005),attestingtotheirrelevancetonaturally
occurring cancers.
Transcriptional regulation of the proliferation
cluster genes
We next turned to identify promoter regulatory motifs that
drive the proliferation cluster. Rather than attempting to
discover de novo promoter motifs, we assumed that transcrip-
tion factors with known binding sites may be involved in
regulating the genes in the cluster. Therefore, we searched
within the promoters of the proliferation cluster genes for the
presence of each of the 326 known vertebrate position-speciﬁc
scoring matrices (PSSMs) from MatInspector (Quandt et al,
1995), using a published gene-to-binding site assignment
algorithm (Elkon et al, 2003). For each PSSM, we calculated a
hypergeometric P-value score (Hughes et al, 2000) to assess
the extent to which it is over-represented among the cluster’s
genes. Noticeably, apart from VMYB, all signiﬁcant motifs
(Table I and Supplementary Table S5) that passed a Bonferroni
test (including NFY, E2F, CHR (Cell cycle genes Homology
Region), ELK1 and CDE (Cell cycle-Dependent Element))
are known to be involved in the regulation of cell cycle
(Mantovani,1998; Badieet al, 2000; Manni et al, 2001; Nevins,
2001; Matuoka et al, 2002; Bracken et al, 2004; Buchwalter
et al, 2004). We therefore focused on these cell cycle motifs in
all subsequent analyses. We have also examined the presence
of the motifs in the 50 UTRs of the cluster’s genes and found
only barely signiﬁcant over-representations in the cluster (see
Supplementary Table S2), and have thus decided to concen-
trate only on the upstream regions in all further analyses.
Evolutionary conservation of the motifs
We examined promoters of mouse genes orthologous to
the proliferation cluster genes and found that the same motifs
are also signiﬁcantly over-represented in these promoters
compared to the promoters in the rest of the mouse genome
(Supplementary Table S3). We have further assessed con-
servation at an organization level beyond the mere presence/
absence of motif, namely conservation of the motif archi-
tecture between the two species. We found considerable
conservation at this level too, using two criteria: ﬁrst, the
combinations of motifs that regulate orthologous promoters
were signiﬁcantly more similar to each other compared to
combinations of non-orthologs (Supplementary Figure S3A).
Second, we found a signiﬁcant tendency to preserve the
locations of the motifs relative to the transcription start
site (TSS) in orthologous promoters (Supplementary Figure
S3B–F). The high level of conservation observed attests to the
functional role of the motifs in these promoters.
Revealing a hierarchy of regulatory motif
combinations
For each motif, we identiﬁed a sequence window relative to
TSSinwhichitisover-represented(Figure2;seeMaterialsand
methods). Here and in subsequent analysis, a motif was
considered present in a promoter if it appeared in its preferred
location. Wenextturnedto identifycombinationsof themotifs
using ‘synergy’ (Pilpel et al, 2001; Banerjee et al, 2003; Garten
et al, 2005) and rate of cooccurrence (Sudarsanam et al, 2002;
Elkonet al,2003).Apairofmotifs wasconsidered‘synergistic’
iftheextentofexpressioncoherence(Pilpeletal,2001;Lapidot
et al, 2003) of genes containing both motifs in their promoters
is signiﬁcantly greater than that of genes containing either of
the motifs alone. A pair of motifs was considered highly
cooccurring if there is a signiﬁcant overlap (using hypergeo-
metric) between the set of genes containing the two motifs,
given the number of genes containing each motif alone. We
foundthatNFY,E2F,CDE,andCHRshowmultipleinteractions
with each other, many of which were supported by both
synergy and cooccurrence. On the other hand, the ELK1 motif
cooccurssigniﬁcantly with E2Fand CDE, and it has synergistic
effect only E2F (Figure 3A). The above interactions were
derived by considering all the genes represented on the array.
Yetmanyoftheinteractionsareobservedalsowhenonlygenes
in the proliferation cluster are considered (Figure 3).
In order to gain more insight into such motif interactions,
we used the Combinogram analysis (Pilpel et al, 2001). We
searched for the above ﬁve regulatory motifs within
the promoters of all varying genes represented on the array.
Wepartitionedthearraygenesintoupto2
5¼32genesets,each Table I Over-represented regulatory motifs in the proliferation cluster
Motif Number of genes containing
motif among the proliferation
cluster/entire array
Over-representation
P-value
NFY 77/1574 9.92E 12
E2F 85/2617 3.57E 07
CDE 101/3073 2.20E 09
ELK1 38/960 4.32E 05
CHR 10/63 5.43E 07
CHR-NFY-CDE 9/12 1.18E 13
The number of genes that contain the corresponding motif in their promoter
among the proliferation cluster (out of 165 genes) and among the entire array
(out of 8110 genes). A hypergeometric P-value score was calculated in order to
assess the extent to which a motif is over-represented in signiﬁcant location
among the cluster’s genes compared to the rest of the genes on the array.
TSS 50 100 150 200
NFY
E2F
ELK1
CDE
CHR
Figure 2 Motif positional bias in promoters of the proliferation cluster genes.
The preferred window position of the ﬁve regulatory motifs, NFY.01, CDE, CHR,
ELK1, and E2F.02, in the promoters of the proliferation cluster genes is shown.
The CHR motif has also a clear strand bias (depicted by a directional arrow); for
more details, see Supplementary Figure S6.
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or absence of each of the ﬁve motifs in their promoters, and
grouped together genes with identical binary signatures. The
Combinogram depicts the motif content of each gene set
(binary black and white matrix), the similarity between the
average expression proﬁles of all pairs of gene sets (upper part
of the dendrogram), and the averaged expression proﬁles of
the genes in each set (expression matrix at the bottom part).
The Combinogram in Figure 3B, which was obtained with 18
gene sets that were populated with genes (14 other potential
sets were not populated with genes), reveals several clear
trends. First, although the analysis was applied to all the genes
represented on the array, that is, without a preceding
clustering stage, a division (corresponding to the main
branching point of the dendrogram, marked ‘1’) into genes
that contain some of the motifs, and genes that do not,
appears.Genesetsthat aretotheleftofbranchpoint‘1’largely
representthe proliferation cluster signature, whereasgene sets
that are on the right branch display no particular trend. The
motifs that appear to determine this split are mainly ELK1, or
NFY and CHR. Genes that contain none of the ﬁve motifs
(column #14 from left) display the ﬂat proﬁle, as do genes that
contain one or two of the motifs, but not ELK1 (columns 11–18
from left). The left branch, which largely shows the prolifera-
tion signature, may be further divided (branch point ‘2’) into
gene sets that contain at least ELK1 (columns 1–8) versus gene
sets that contain NFY and CHR, but not ELK1. These
differences in motif composition reﬂect themselves at the
level of expression pattern—without ELK1, a clear decrease in
expressioninthesenescence(40)andsenescenceGSE(4)time
points (thirdand fourth rows of the expression matrix) is seen,
whereas an increase in expression in the last two time points
is evident too. The presence of ELK1 appears to be both
necessary and sufﬁcient for its typical dictated expression
pattern, as genes that contain only ELK1 (column 5) are
members of the ELK1 cluster and genes that do not contain
ELK1 (columns 9–18) are not in the cluster. Branch point ‘3’
further sharpens the ELK1-dictated signal. Genes that contain
ELK1 andNFY (columns 6–8) arelocated to theright ofbranch
point ‘3’, as they display an intermediate between the pure
ELK1 pattern and the NFYand CHR pattern, while genes to the
left of this branch point display a distinct pattern. In general,
this analysis shows a striking correspondence between motif
content and gross and ﬁne differences in expression, akin to a
previous, yet simpler, observation made in yeast (Pilpel et al,
2001). It allows the dissection of the role of individual motifs
and their combinations (e.g. the effect of CHR on the
background of NFY and CDE is clear from the difference in
expression patterns between columns 10 and 11 in which CHR
is present and absent, respectively). This analysis strongly
suggests that indeed the ﬁve regulatory motifs examined here
govern gene expression proﬁles during the transformation
process and that the proliferation signature represents a
response genuinely regulated by these motifs.
Next, we examined whether it is possible to trace the
regulatory effect of these motifs down to the relatively
microscopic time scale of single cell cycle divisions. We tested
whether the motif architecture we discovered here also
governs the expression of these genes during cell cycle
divisions. To this end, we constructed a Combinogram based
on the ﬁve motifs together with cell cycle expression data
derived from the HeLa cell cycle experiment described above
(Whitﬁeld et al, 2002; Figure 3C). Notably, we observed
similar relationships between motif combinations and their
effects on expression in both the transformation and the cell
cycle experiments. In both experiments, NFY appears to
interact synergistically with CHR, an interaction that gives
rise to a clear G2–M phase expression pattern in cell cycle.
Here, the presence of the CDE motif further ampliﬁes this
pattern. The resemblance between the transformation and the
cell cycle experiments indicates that the transcriptional
regulation of the cluster during the complex and largely
uncharacterized 600-day-long transformation process can be
reduced to the more ‘atomistic’ level of the regulation of cell
cycle.Interestinglythough,inthecellcycleexperiment,wedid
not detect any clear pattern dictated by E2F, alone or through
combinations with other motifs, suggesting either that despite
intensive research on this transcription factor, an accurate
description of its binding site is still missing, or that its
regulatory role is too complex and diverse (Bracken et al,
2004). This too is consistent with a recent observation (Elkon
et al, 2003) that although E2F is over-represented in the
promoters of cell cycle genes, it is not restricted to genes that
peak at a speciﬁc cell cycle phase. Likewise, the ELK1 motif
does not seem to affect gene expression throughout the cell
cycle. The observation that the E2F and ELK1 motifs affect
transcriptionmainlyinthetransformationexperimentandless
so in cell cycle may indicate that their role in the transforma-
tion process is not mediated through a direct effect on the
cell cycle, but rather on a potentially higher level. Another
potential explanation for the fact that presence of either ELK1
motif or the combination NFYand E2F was signiﬁcant in the
transformation experiment but not in HeLa cell cycle experi-
ment may berelatedtothe factthat in HeLacells,both p53and
pRb are inactivated by the viral oncoproteins E6 and E7. Thus,
if the ELK1 motif or the combination of NFY and E2F
potentially mediates growth restrictive effects of these major
tumor suppressive pathways, we would not expect these
effects to be manifested in HeLa cells.
The proliferation cluster genes integrate
information from two tumor suppressive channels
Our knowledge of the detailed molecular history of the
transformation processin the experiment allowed us to extend
our analysis beyond the formation of links between regulatory
motifs and expression proﬁles. Since the activity of upstream
tumor suppressors was manipulated and monitored during
the transformation, we could link gene expression patterns,
mediated by various regulatory motifs, to activity of tumor
suppressors. In particular, we followed the activity levels of
two prime tumor suppressor genes, p53 and p16, that varied
throughout the transformation process. Since p53 was
inactivated at the protein level, we used as a surrogate for
its activity mRNA levels of its regulated target, p21, which
is indeed downregulated in response to p53 inactivation
(Figure 4A).
First, we observed that while the averaged mRNA proﬁles of
the genes in the cluster do not correlate with the mRNA levels
of either p21 or p16 alone, they show high negative correlation
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expression proﬁles of these two genes (Figure 4A). This is a
signiﬁcant correlation, as the probability of pairs of random
genes that are summed up to obtain such correlation or lower
with the proliferation cluster’s average is o1% as estimated
by 10000 random samples. Simple logical functions such as
AND or OR gates, applied to the combination of p21 and p16,
were unable to describe the activity levels of the genes in the
cluster. The promoters of these genes thus appear to sum
up the expression levels of the two tumor suppressors and
produce a corresponding output in the form of expression
proﬁles. Recently, similar ‘sum-gated’ designs were shown
in Escherichia coli (Setty et al, 2003; Kalir et al, 2004).
More importantly, we identiﬁed the promoter motifs that
likely mediate such integrative function. We analyzed sepa-
rately all the genes represented on the array that contain in
their promoters the ELK1 motif, and all genes that contain a
combination of NFYand CHR. Figure 4B shows that genes that
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suppressors, and their expression levels map the presence/
absence of the two suppressors onto four distinct expression
levels (multiple t-tests on all six pairwise comparisons yielded
a signiﬁcant P-value of 0.14 10
 6 or lower). In contrast, the
ELK1 motif mainly mediates a response to the presence/
absence of p16. The expression of ELK1-regulated genes is
signiﬁcantly upregulated following p16 inactivation. Although
the ELK1 transcription factor was previously implicated in the
regulation of expression of proliferation genes (Ullrich et al,
1990;Gilleetal,1995),itspotentialregulatoryinteractionwith
either p16 or p53 was not addressed before.
Three-way linkage of expression, promoter
architecture, and tumor suppressor activity
In order to gain further insights into the relationship between
mRNA expression proﬁles and promoter architecture, we
sorted the proliferation cluster genes using SPIN (Tsafrir et al,
2005), a sorting algorithm that positions genes with similar
expression proﬁles in adjacent rows of an expression matrix
(Figure 5A). We also examined the presence of the regulatory
motifs in promoters of genes in the cluster along the sorted
expression matrix (Figure 5C and D). Interestingly, the CDE
andE2Fmotifsarerelativelyevenlyscatteredalongthecluster.
This, together with the observation that they are signiﬁcantly
highly speciﬁc to the proliferation cluster suggests that these
motifs are major characteristics of the cluster. On the other
hand,theCHRmotifand,toasmallerextent,theNFYmotifare
mainly concentrated in promoters of genes in the ‘upper’ part
of the sorted cluster, while ELK1 mainly shows a preference
toward the genes in the ‘lower’ part. We thus conclude that
while the presence of the CDE and E2F motifs deﬁnes the
cluster and are present in the majority of its genes, CHR, NFY,
and ELK1 serve to modulate the general expression patterns
dictated by CDE and E2F.
Although the averaged expression proﬁle of the cluster
genes is strongly negatively correlated with the summed
expression proﬁles of p16 and p21, and not with the individual
tumor suppressors (Figure 4A), it is still possible that part of
the genes correlate only with p21 while others correlate only
with p16. We have thus measured (Figure 5B) for each gene in
the (sorted) cluster the correlation of its mRNA expression
proﬁle during the transformation process with the expression
proﬁles of p16 and p21 and with the summed proﬁles of p21
and p16 (Figure 5B). Strikingly, for the majority of the genes in
the cluster, the negative correlation with the summed proﬁle
is stronger than with the individual tumor suppressors. This
is predominantly true for the genes in the ‘upper’ part of the
sorted cluster. Although for these genes, there exists also a
negative correlation with p21 alone, they are more strongly
(negatively) correlated with the sum-gate, suggesting that
the motifs regulating these genes are indeed integrating, by
summing up, the information from the two suppressor
channels. The correlation with p21 gradually diminishes with
genes that are located toward the ‘lower’ part of the cluster,
and on the other hand the correlations with p16 level showthe
opposite trend, namely a high correlation with genes in the
lower part of the cluster. We stress that the data suggest no
obvious point where the cluster can be subdivided into two
clustersbasedoncorrelationswith thetwotumorsuppressors.
It was found recently that DNA-binding activity of NFY
transcription factor is positively regulated by CDK2 phos-
phorylation. This may explain the higher sensitivity of
NFY-containing genes to p21 level, as it speciﬁcally inhibits
CDK2 (Weinberg, 1995; Sherr, 1996; Sherr et al, 1999; Hahn
et al, 2002). On the other hand, p16 speciﬁcally inhibits CDK4
and CDK6 (Weinberg, 1995; Sherr, 1996; Sherr et al, 1999;
Hahn et al, 2002). Thus, the increased sensitivity of ELK1-
containingpromoterstop16levelsenablesustoproposenovel
role for CDK4/6 in ELK1 regulation.
The integration of these ﬁndings together with published
experimental data allowed us to propose a network linking
three layers of data—mRNA expression, promoter regulatory
motifs/transcription factors, and the upstream tumor suppres-
sors and signaling molecules (Figure 5E). It is entirely possible
though that additional tumor suppressors and transcription
factors participate in the network, and future analysis may
reveal their identity and role.
Experimental validation of computational
predictions
Our data suggested that the proliferation cluster genes are
subject to p53- and p16-mediated transcriptional repression.
Figure 3 (A) Graph depicting interaction between the ﬁve regulatory motifs measured by synergy and cooccurrence. A pair of motifs connected by a thick red line has
a synergistic effect on expression and pairs connected by a thin blue line are signiﬁcantly more highly cooccurring in individual promoters. These interactions were
computed using all genes on the array. In addition, we calculated cooccurrence interaction given only the genes in the cluster (i.e. considering the total number of genes
in the cluster and the number of cluster’s genes containing each motif as a background), and found even there several signiﬁcant interactions (blue dotted lines). Since
forsomeofthemotifs,themotifdatabasecontainsmultiplevariants,weuniﬁedallvariantsofthesamemotifintoonenode,andanedgeinthegraphconnectstwomotifs
ifatleastoneofthevariantsofthetwomotifsiseithersynergisticorhighlycooccurring.(B,C)Combinogramanalyses(Pilpeletal,2001)usingtheﬁveregulatorymotifs
duringthe transformation process (B)andHeLacell cycle(C). Allthe varying genesinthe respectivearrays were usedinthe analysis.Theupper andmiddleparts of the
Combinogramaredepictedasbefore(Pilpeletal,2001),whilethelowerpartismodiﬁed.Brieﬂy,themiddlesectionoftheCombinogramdepictsthemotifcompositionof
each gene set deﬁned by motif combination (GMC; see Materials and methods). Each vertical column represents a single GMC. A black square indicates that the
particular motif is present in the promoters of all the genes in that GMC. A white square indicates that none of the genes in the GMC contain the particular motif. The top
section of the graph shows the dendrogram analysis that assesses the similarity in expression proﬁles of each GMC using normalized Euclidean distances between the
averageexpressionproﬁlesofthegenesintheGMCasameasureofdistance.ThelowerpartofthismodiﬁedCombinogramdisplaysthemeanexpressionproﬁlesofthe
genes in each GMC; color-coded as in Figure 1. The numbers of genes in each GMC appear below the dendrogram. The three main branch points in the dendrogrami n
(B)are representedas1–3(incircles).Inthepresentanalysis,onlygenesthatcontainthemotifs intheir preferreddistancerelativetoTSS(asdepictedinFigure2)were
considered,asgenesthatcontainthemotifs,yetawayfromthepreferredlocation,displaynoclearexpressionpatterns(notshown).SinceCHRmotifhasastrongstrand
bias in addition, and since genes that contain this motif yet on the nonpreferred strand have a non-coherent expression proﬁle (Supplementary Figure S6), for this motif
we considered only genes that contain it in the preferred strand and distance from the TSS.
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CCNA2, BIRC5, CDC2, CDC25C, PRC1, POLD1, PLK, and
others were previously shown to be downregulated by p53
(Yamamoto et al, 1994; Wang et al, 1997; Yun et al, 1999;
Krause et al, 2000;Hoffman et al, 2001; Tang et al, 2001; Manni
et al, 2001; Burns et al, 2003; Li et al, 2004; St Clair et al, 2004),
validating our analysis and enabling us to propose numerous
novel p53 transrepression targets. Interestingly, multiple
components of the kinetochore complex and most of the
known spindle checkpoint genes are found in our proliferation
cluster. Since p53 was not previously implicated in the
regulation of this group of genes, we decided to test for p53-
mediated transcriptional repression of several genes from this
category. Importantly, the regulatory network we proposed,
based on the microarray experiment conducted under basal
unstressed conditions, is expected to hold for cases where
the upstream tumor suppressors are induced either by forced
overexpression or by stress. We therefore tested whether a
stress-induced p53 will repress the expression of several
kinetochore/spindle genes. To this end, we treated normal
and GSE56-expressing WI-38 cells with doxorubicin, a DNA-
damaging agent and a potent p53 activator, and measured the
levels of several proliferation cluster-derived genes by quanti-
tative real-time PCR (qPCR). Conﬁrming our hypothesis, we
found that following DNA damage, Cdc20, Bub1, CCNF,
and Mad2L1, all of which are cluster members, were down-
regulated in normal WI-38 cells, but not in their isogenic
counterparts, in which p53 was inactivated (Figure 6). Thus,
these kinetochore- and spindle checkpoint-related genes repre-
sent novel targets of p53-mediated transcriptional repression.
Since our computational analysis revealed that the proli-
feration cluster genes display a negative correlation with p21
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Figure 4 (A) Normalized expression proﬁles of the tumor suppressors p21 (brown line) and p16 (black line), along with a proﬁle that represents the average of their
proﬁles (green area) and a proﬁle that represents the mean expression proﬁles of the genes in the proliferation cluster (blue area). (B) Average expression proﬁles of all
genesinthegenomethatcontainElk1intheirpromoters(left)andtheNFYandCHRmotifs(right).Eachbarrepresentsanaverageoverthesamplesthatcorrespondsto
low expression (o 0.3) denoted by ‘L’ and high expression (40.2) denoted by ‘H’ of the normalized mRNA expression levels of p21 and p16.
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proliferation cluster genes via p21 induction. To this end, we
treated the HCT-116 colon carcinoma cells and their p53-null
and p21-null derivatives with doxorubicin. We measured the
expressionlevelsofseveralproliferationclustergenesbyqPCR
and calculated the fold repression for each gene as the ratio of
expression level in nontreated cells to that in doxorubicin-
treated cells (Table II). Notably, only cells that contained
both functional p53 and p21 (HCT-116 p53þ/þ) displayed
downregulation of these genes following DNA damage. This
supports the notion that the proliferation cluster genes are
transcriptionally repressed by p53, and suggests that this
repression is mediated through p21.
In order to gain further insights into the mechanism of
p53-dependent repression of the proliferation cluster genes,
we decided to focus our efforts on the cdc20 gene as a
representative member of the cluster. We cloned the cdc20
promoter into a luciferase reporter vector and transfected it
into HCT-116 p53 /  cells with or without a p53 expression
plasmid.AsindicatedinFigure7A,inthepresenceofwild-type
p53,theactivityofcdc20promoterwassigniﬁcantlyrepressed.
In contrast, a p53 mutant lacking a functional transactivation
domain (L22Q/W23S) did not repress cdc20. The requirement
for a functional transactivation domain supports our conclu-
sion that cdc20 repression by p53 is indirect and is mediated
by induction of a mediator gene. Cotransfection of cdc20
promoter reporter with the p16 expression vector also resulted
in repression of promoter activity (Figure 7A), supporting our
prediction that the proliferation cluster genes integrate signals
from both p53 and p16.
Since promoters of the proliferation cluster genes are highly
enriched with E2F motifs, we tested whether cdc20 promoter
activity is affected by the presence of an E2F1 dominant-
negative protein (E2F-dTA) that is capable of DNA binding but
defective in its transactivation and RB-binding domain.
Overexpression of this construct displaces the endogenous
E2F proteins from the DNA, abolishing both activation and
repression by E2F family members (Hofmann et al, 1996). As
demonstrated in Figure 7B, cdc20 promoter activity decreased
in the presence of a dominant-negative E2F1, and p53 did not
repress it further under those conditions (see ﬁgure legend for
details). The most signiﬁcantly enriched motif in the prolifera-
tion cluster promoters is NF-Y, suggesting the involvement of
its cognatetranscriptionfactor intheregulationofthecluster’s
genes. To validate this hypothesis, we tested whether cdc20
reporter activity is affected by the presence of an NF-Y
dominant-negative protein (Mantovani et al, 1994). Indeed,
overexpression of a dominant-negative NF-YA (dnNF-YA)
resulted in reduction of cdc20 promoter activity and in strong
attenuation of the p53-dependent repression of this promoter.
These results indicate that both the E2F family of transcription
factors and the NF-Y transcription factor participate in cdc20
regulation, and that p53-dependent repression of cdc20 is
mediated through these proteins.
Finally, we addressed the signiﬁcance of the NF-Y motifs
found in the cdc20promoter for p53-mediated repression.Two
NF-Y motifs reside in cdc20 promoter within the ﬁrst 100bp
relative to the TSS. We generated cdc20 promoter reporter
constructs that harbor mutations in each of the motifs and an
additional construct with both NF-Y motifs mutated. These
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Figure 5 Three-way linkage between expression proﬁles, promoter architecture, and tumor suppressor pathways. (A) The entire expression matrix of the proliferation
cluster genes, sorted with SPIN (Tsafrir et al, 2005), revealing an ‘elongated’ shape for this cluster. (B) Correlation coefﬁcient between p21 and p16 expression proﬁles
to each of the genes in the cluster; color-coded according to color bar shown. (C) Cumulative distribution of CHR, ELK1, and NFY along the sorted list of genes in (A).
(D) Bars depicting main areas of density of regulatory motifs along the sorted expression matrix in (A) are based on cumulative appearance in (C). (E) Arrows in the
networks represent positive (green) or negative (red) interactions. Reviewed: 1—Ullrich et al (1990); 2—Gille et al (1995); 3—Serrano et al (1997), Lin et al (1998),
Zhu et al (1998); 4, 5, 7, 9–11—Weinberg (1995), Sherr (1996), Sherr et al (1999), Hahn et al (2002); 6—el-Deiry et al (1993); 8—Yun et al (2003); 12—newly
proposed interaction (this paper).
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for their responsiveness to p53 status by cotransfecting them
into HCT-116 p53þ/þ cells in the presence or absence of a
dominant-negative p53. While mutation of each NF-Y site
alonedidnotaffectp53-mediatedrepression(datanotshown),
mutations in both NF-Y motifs resulted in signiﬁcant attenua-
tion of the repression (Figure 7C). These results support our
computational prediction that NF-Y motifs, enriched in the
promoters of the cluster genes, are involved in the regulation
of these genes by p53.
Discussion
This study describes the analysis of genome-wide expression
proﬁles of an in vitro transformation process. Focusing on a
well-deﬁned expression cluster that consists predominantly of
core cell cycle genes, we identiﬁed promoter motifs and their
combinations that regulate the transformation process. We
suggest that at least part of such regulation can be explained
by a direct effect on cell cycle progression. Working with
a controlled transformation process allowed us, for the ﬁrst
time, to not only establish a connection between gene
expression and promoter architecture, but also to identify
links to the activity of upstream tumor suppressors. Such
a three-way connection was most revealing, as it identiﬁed
promoter motifs that likely ‘count’ the number of active tumor
suppressive channels and map them onto distinct expression
states. Finally, detailed experimental analyses of selected
genes experimentally established many of the suggested
components of the network.
The two tumor suppressors studied here, namely p53 and
p16, mainly respond on cell intrinsic and environmental
signals, respectively. Thus, the promoter architecture discov-
ered in this study integrates internal and external signals that
affect core cell cycle genes. Such integration is performed by
summing up activity from the two suppressive channels and
mapping the result onto distinct expression levels. The
intermediate expression level states, which correspond to
precisely one active suppressive channel, may represent an
‘undecided’state.Suchastatemightbefollowedbyeitherhigh
or low expression states of the cell cycle genes that may ensue
after inactivation or activation of the second channel,
respectively. Residing in such intermediate state can facilitate
more rapid transition to one of the two extreme stages in
response to addition or removal of intrinsic or environmental
suppressive signal. In this respect, it is crucial to note that the
expression levels of the cluster’s genes are correlated with
proliferation rate (Figure 1B); thus, promoter tuning of
transcription of at least some of the genes may affect
proliferation.
It is well known that activation of p53 leads to induction of
p21 and inhibition of CDK2 activity (Weinberg, 1995; Sherr,
1996; Sherr et al, 1999; Hahn et al, 2002). As depicted in
Figure 5E, CDK2 controls E2F indirectly (through inactivation
of RB by phosphorylation) and NFY directly (through CDK2-
mediated phosphorylation). The CHR (cell cycle genes
homology region) and the CDE (cell cycle-dependent element)
represent ‘orphan’ binding sites, as the factors that bind these
motifs are still uncloned (Zwicker et al, 1995). These two
elements are often found in close proximity to each other and
these CDE/CHR ‘tandems’ were shown to be important for the
cell cycle-dependent expression of many genes. However, not
always these two sites appear together. For example, a single
CHR was shown to control cell cycle-dependent transcription
of the cdc25C phosphatase gene and to cooperate with E2F or
Sp1/3 sites (Haugwitz et al, 2002). Our genome-wide analysis
strongly suggests the existence of a novel strong functional
cooperation betweenCHRandNFYelements.Accordingto our
Combinogram analysis, the presence of these two sites in the
proximal 200bp upstream of the TSS is sufﬁcient to dictate
a G2/M expression pattern of multiple genes (Figure 3C). In
Figure 6 p53 represses proliferation cluster genes expression following DNA
damage. Normal and GSE56-expressing WI-38 cells were treated with 0.2mg/ml
doxorubicin (dox) for 48h. mRNA levels for the indicated genes (y-axis) were
measured by qPCR and normalized to the GAPDH housekeeping control.
Table II p53- and p21-dependent repression of the proliferation cluster genes
expression
Fold repression
Gene symbol HCT116
p53+/+
HCT116
p53 / 
HCT116
p21 / 
Cdc20 2.6 1.2 0.7
BIRC5 1.6 0.6 0.7
NEK2 1.8 0.5 0.9
Mad2L1 2.4 0.7 0.8
Bub1B 1.7 0.8 1.1
PRC1 1.7 0.9 0.9
CENPF 1.7 0.7 1.2
HCT-116 cells containing wild-type p53 and their p53-null and p21-null
derivatives were treated with 0.2mg/ml doxorubicin for 48h. The expression
levelforeachgenewasmeasuredbyqPCRandnormalizedtoGAPDHexpression
level. The numbers in the table represent fold repression, calculated for each
gene as the ratio of expression level in nontreated cells to doxorubicin-treated
cells.
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ture, namely the combination of NFYand CHR, is responsible
for the integration of inputs from p21 and p16 during the
in vitro transformation process.
ELK1 transcription factor is a known downstream target of
the MAP kinase pathway. It was demonstrated that prolif-
erative inputs from deregulated MAP kinase pathway are
counteracted by a negative feedback loop involving p16
activation with subsequent inhibition of CDK4/6 activities
(Serrano et al, 1997; Lin et al, 1998; Zhu et al, 1998).
Interestingly, our results indicate a strong negative correlation
between the activities of ELK1-containing promoters and the
expression level of p16, suggesting a possibility that p16
inhibits the activity of ELK1. To the best of our knowledge, this
relationship was not reported previously. Since p16 speciﬁ-
cally inhibits CDK4 and CDK6, it is possible that phosphoryla-
tion by these kinases plays a role in ELK1 regulation.
Many genes in the proliferation cluster represent previously
identiﬁed targets of p53-mediated transcriptional repression.
Our results signiﬁcantly broaden the list of potential p53
transrepression targets. Here, for example, we identiﬁed an
entire set of kinetochore/spindle genes, the expression of
which is negatively regulated by p53. The functional sig-
niﬁcance of this ﬁnding is still unclear but it is tempting to
speculate that loss of this transcriptional control contributes to
aneuploidy formation, which is frequently found in tumors
with mutated p53.
An additional important conclusion of our study relates to
the mechanism of p53-mediated transcriptional repression.
Unlike transactivation by p53, which clearly requires p53
binding to the regulatory sequences of targets, the mechan-
isms of repression by p53 are less well understood. The
promoters of repressed genes usually do not contain p53-
binding sites. Various mechanisms of p53 transrepression
were proposed (for review, see Ho et al, 2003). In addition,
it was recently demonstrated for several genes that p53-
mediated transcriptional repression requires the induction of
p21 (Lohr et al, 2003). Our study addresses systematically this
point using the three-way linkage of expression, promoter
architecture, and tumor suppressor activity. We found that
transcriptional repression by p53 is in most cases indirect,
mediated by p21 induction. The signal is then transduced to
E2F/CDE, NF-Y, and CHR motifs in the promoters of target
genes.
Finally, it is crucial to note that the proliferation signature
has clear relationship with naturally occurring tumors. Rosty
etal(2005)haveidentiﬁedaclusterofgeneswhoseexpression
Figure 7 (A) The cdc20 promoter is repressed by wild-type p53 and by p16,
butnotbyatransactivation-deﬁcientp53mutant.Normalizedluciferaseactivityof
the p-cdc20-luc reporter in HCT-116 p53 /  cells is shown. cdc20 promoter
activity in the absence (control) or presence of either wild-type p53 (wt-p53), the
L22Q/W23S p53 mutant (p53 22,23), or p16. (B) cdc20 promoter is regulated by
E2F and NF-Y. Normalized luciferase activity of p-cdc20-luc reporter in HCT-
116 p53 /  cells. cdc20 promoter activity in the absence or presence of wild-
type p53and inthe presence ofeither control vector (control), dominant-negative
E2F1 (E2F-dTA), or dominant-negative NF-YA (dnNF-YA). Fold repression was
calculated as the ratio of promoter activity in the absence of wt-p53 to the level in
its presence, and was signiﬁcantly lower in the presence of dominant-negative
E2F1 and dominant-negative NF-YA compared to control (paired t-test
P-values¼0.03 and 0.01, respectively). (C) NF-Y motifs are important for p53-
mediated repression of the cdc20 promoter. The wild-type promoter construct
p-cdc20-lucandaconstructwithbothNF-Ymotifsmutated(mutantNF-Y1þ2)
were cotransfected into HCT116 p53þ/þ cells in the presence or absence of a
dominant-negative p53 (p53-DD). Fold repression was calculated as the ratio of
promoter activity in the presence of p53-DD to control and was signiﬁcantly lower
for the mutant NF-Y 1þ2 construct (P-value¼0.005). Data represent the
average of three independent experiments, each performed in triplicate.
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human patients with cervical cancer; low levels of expression
characterized a subset of the patients with good outcome. In
ourpreviouswork(Milyavskyetal,2005),wehaveshownthat
there is a signiﬁcant overlap between our proliferation cluster
and that reported by Rosty et al, and we mentioned there other
indications of additional proliferation cluster genes that
constitute good predictors of relapse. We are aware, however,
of the fact that such common features should be carefully
evaluated using additional natural malignancies. In addition,
in the future, similar transformation processes, performed
with additional cell lines, may be important for further
establishing the generality of the signatures derived here. In
this respect, we note that in our previous work (Milyavsky
et al, 2005) we addressed this issue by monitoring similar
molecular events, such as INK4A locus inactivation in two
additional cultures, supporting the generality of our ﬁndings.
Materials and methods
Promoter sequence
DNA sequences upstream of human ORFs were downloaded from the
GoldenPath server at UCSC http://genome.ucsc.edu/goldenPath/
hg16/bigZips/. Putative regulatory regions (1000bp upstream of the
TSS) for the different genes were obtained. We used for the original
experiment (Milyavsky et al, 2005) the GeneChip Human Genome
Focus Array (Affymetrix, Santa Clara, CA) that represents over 8500
veriﬁed human sequences from the NCBI RefSeq database. We
identiﬁed promoters for 8110 genes out of the 8500. Of the 8110 genes,
we have selected 5582 genes that had a ‘present call’ (according to
Affymetrix calling procedure) in the two duplicates of at least one
sample.Ofthe168genesintheproliferationcluster,141probesetshad
a promoter in GoldenPath. When morethan one probe set on the array
corresponded to same genomic locus (e.g. owing to alternative
splicing), we considered the corresponding regulatory region only
once.
While the present analysis covers only the 8500 genes represented
on the GeneChip Focus Array that was used in our original experiment
(Milyavsky et al, 2005), we have also examined the promoter motif
content of all B33000 genes that were represented on the U133 Array
(Affymetrix, Santa Clara, CA). We found additional 2316 genes that
werenotrepresentedontheFocusArraythatcontainatleasttwoofthe
discovered transcriptional modules; 36 of them contain four of the
motifs analyzed here (see Supplementary Table S4). These genes may
represent additional candidates for the network discovered here.
A collection of position-speciﬁc scoring matrices
We used the MatInspector library of 326 PSSMs maintained by
Genomatix (Release 4.1) (Quandt et al, 1995) and a customary
promoter to PSSM assignment score (Elkon et al, 2003). We then
identiﬁed a threshold on this score, above which a PSSM is considered
assignedtoapromoter.Forthis,weusedthegenesinaclusterandfora
range of potential values of the threshold score we calculated, using
the hypergeometric statistic, the groups speciﬁcityscore(Hughes et al,
2000) of the motif relative to the genes in the cluster. We identiﬁed and
adopted the threshold score that minimizes the hypergeometric
probability function. See Supplementary Figure S5 for examples for
threshold score determination for a selection of motifs. Only motifs
that passed the Bonferroni correction for multiple hypotheses testing
(that considered the multiple attempted thresholds) were retained.
Assessing motif positional bias
Positional bias was previously deﬁned as the extent to which a motif
that is assigned to a set of promotersis enriched in a sequencewindow
(deﬁned in terms of distance relative to the TSS) of a ﬁxed length (e.g.
50bp) with the maximal number of promoter (Hughes et al, 2000).
Althoughefﬁcientandsimple,thisalgorithmhasalimitationofhaving
to deﬁne a ﬁxed length window, without a priori knowledge about the
relevant window width. We thus devised the following alternative
procedure that learns thewindow’swidth fromthe data. We search for
the window that is most enriched with occurrences of the motif using
the following procedure:
1. Assume we have N occurrences of the motif in the
promoters of the cluster’s genes. Denote their (ordered)
distances from the TSS (of each gene) by Ci (i¼1,y,N),
such that 0pC1p?pCNo1000.
2. A window is deﬁned as a subinterval [a,b]C[0.1000]. We
search for the window that is most enriched with motifs,
compared to a random background model. For each
window [a,b], we denote by M(a,b) the number of
motifs Ci with distance of at least a and no more than b
from the TSS. The background distribution of the number
of motifs in the window [a,b]i sM(a,b)BBinomial
(N,( b aþ1)/1000). Since windows overlap, an enrich-
ment of a speciﬁc window leads to enrichment of windows
overlapping it. Thus, we deﬁned the most enriched
window to be the one with smallest background proba-
bility, that is, the interval [a,b] minimizing Pr(M(a,b))
under this background model. Obviously, the densest
window is [Ci, Cj] for some ipj; therefore, we can restrict
our search only for intervals of the form [Ci, Cj]. Thus, it
is deﬁned as Wmin¼argmini,jPr(M(Ci, Cj)Xj iþ1), with
Pmin¼mini,jPr(M(Ci, Cj)Xj iþ1)).
3. To test statistical signiﬁcance of the densest window, the
distribution of Pmin in the background model is required.
This was calculated by simulations. For N from 2 to 300,
we have performed 100000 simulations, each time select-
ing N points randomly in [0.1000] and then computing
Pmin. This gave an empirical distribution denoted FN,min.
The P-value for the observed most enriched window is
simply FN,min(Pmin).
Combinogram analyses
TheanalysiswasinitiatedwithasetofNmotifs.Eachofthe5582genes
was assigned with a binary signature of length N with a 1 at the ith
position if the gene contains motif i in its promoter, and a 0 otherwise.
Thus, 2
N gene sets (that constitute the ‘power set’ of the set N), termed
genes deﬁned by motif combinations (GMCs), were generated
where all the genes in a given GMC share the same subset of the N
motifs. The averaged expression proﬁle of all the genes in each GMC
wasdetermined.ThenormalizedEuclidiandistancebetweenaveraged
expression proﬁles for all pairs of GMCs was calculated and served as
the input for the dendrogram analyses that were generated with the
Cluster Analysis module in Matlab 7 (Mathworks) using the average-
linkage option.
Cell lines
WI-38 cells were maintained in MEM supplemented with 10% FCS,
1mM sodium pyruvate, 2mM L-glutamine, and antibiotics. Cells
were passaged and counted once in 5–7 days. The HCT-116 cells and
their p53-null and p21-null derivatives were a gift from B Vogelstein
(The John Hopkins University, Baltimore, MD) and were described
by Bunz et al (1998). HCT-116 cells were maintained in McCoy’s
medium supplemented with 10% FCS, 1mM sodium pyruvate, 2mM
L-glutamine, and antibiotics. All cell lines were grown at 371Ci na
humidiﬁed atmosphere of 5% CO2 in air.
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The construct p-cdc20-luc was generated by cloning cdc20 promoter
and50-UTRintoaluciferasereporter.Brieﬂy,agenomicfragmentofthe
cdc20 promoter, spanning from  1002 to þ229 relative to the TSS,
was ampliﬁed by PCR with the primers 50-tccacctctgagcacattcat-30 and
50-tccttgcagttggtgcct-30, using Expand Long Template PCR system
(Roche). The ampliﬁed region was cloned into pGEM-T easy vector
(Promega)andthentransferred intopGL3superbasicvector(giftfrom
M Oren, Weizmann Institute of Science) using the restriction enzymes
NdeI and NcoI. Mutations in NF-Y motifs were generated on the
template of p-cdc20-luc using the QuikChange Site-Directed Mutagen-
esis kit (Stratagene) with the following primers (mutations are in
uppercase): for mutation of NF-Y motif at position ( 83), cccttcgccgg
agaggTAGTAgggctagggcaacggttgc, and for mutation of NF-Y motif at
position ( 38), gacggttggattttgaaggagAAGTAaggcgctcggagcggagagt.
Expression plasmids for wild-type human p53 and mutants L22Q/
W23S were gifts of C Hurris (NIH, Bethesda, USA) and were described
by Zhou et al (1999). Expression plasmid for the p53 dominant-
negative peptide (p53-DD) was a gift of M Oren and was described by
Shaulian et al (1992). Expression plasmid for p16 was kindly provided
by R Agami (Netherlands Cancer Institute). E2F-dTA expression
plasmid pRcCMVE2F1-(1–363) was as described by Hofmann et al
(1996). dnNF-YA expression plasmid NF-YA13m29 was described by
Mantovani et al (1994).
Transfections and reporter assays
HCT-116 cells were plated at 3 10
4cells/well in a 24-well plate 48h
before transfection. Cells were transfected using JetPEI (Polyplus
Transfection), with 150ng/well of luciferase reporter, 50ng/well of
pCMV-b-galactosidase expression vector, and appropriate expression
plasmids for a total DNA amount of 1mg/well. The p53 expression
plasmids were transfected at 10ng/well. The p16, dnNF-YA, and E2F-
dTAexpression plasmids were transfected at 300ng/well. Cell extracts
were prepared 48h after transfection, and luciferase and b-galactosi-
dase activities were determined using commercial reagents and
procedures (Promega). Statistical signiﬁcance was determined by
paired t-test.
RNA preparation, cDNA synthesis, and qPCR
Total RNA was extracted with the Versagene RNA cell kit and was
treated with the Versagene DNase treatment kit (Gentra Systems Inc.).
A2 mg aliquot of the RNA was reverse transcribed using MMLV-RT
(Promega) and random hexamer primers (Roche Applied Science).
qPCR was performed using SYBR Green PCR Master Mix (Applied
Biosystems). The expression level for each sample was normalized to
that of the GAPDH housekeeping gene in the same sample. Primer
sequences were as follows:
GAPDH, 50-agcctcaagatcatcagcaatg-30 and
50-cacgataccaaagttgtcatggat-30;
cdc20, 50-gagggtggctgggttcctct-30 and
50-cagatgcgaatgtgtcgatca-30;
CCNF, 50-catctgcacccggtttatca-30 and
50-cttccaaggcggagacga-30;
BIRC5, 50-tcatccactgccccactga-30 and
50-agaagaaacactgggccaagtc-30;
MAD2L1, 50-gttggaagtttcttgttcatttgatct-30 and
50-ggtcccgactcttcccattt-30;
CENPF, 50-agaaagcagtcatgagtggtattca-30 and
50-gcaggatatatgggctagtctttcc-30;
PRC1, 50-acaaaccgaggaggaaatcttct-30 and
50-caattcgtgccttcaactcttct-30;
Bub1b, 50-tacactggaaatgaccctctggat-30 and
50-tataatatcgtttttctccttgtagtgctt-30.
Supplementary information
Supplementary information is available at the Molecular Systems
Biology website (www.nature.com/msb).
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